Drug Policy Archives - Page 3 of 57

State attorneys general ask Congress to undermine their state hemp laws

Commentary by Michelle Minton

Modernizing addiction regulations: How licensing, telehealth, and delivery reform can expand access to care

Commentary by Layal Bou Harfouch and Edward Timmons

Ibogaine could transform public spending on opioid treatment

Backgrounder by Madison Carlino

FAQ: Timeline for FDA ibogaine approval

FAQ by Gregory Ferenstein

Ibogaine and veterans’ mental health

Backgrounder by Aubri Strachan

Ibogaine offers breakthrough treatment for mental health, addiction, and TBIs

Backgrounder by Aubri Strachan

Best practices to prevent misuse of opioid settlement funds

Commentary by Layal Bou Harfouch and Mariana Trujillo

Psychedelics Policy Newsletter: DEA considers rescheduling psilocybin, FDA releases rejection decision, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — October 2025

Commentary by Gregory Ferenstein

More Drug Policy

Prev
1
2
3
4
5
6
7
...
57
Next